These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

391 related items for PubMed ID: 11100668

  • 1. [G-CSF versus GM-CSF in the treatment of neutropenia in a patient with Felty's syndrome on hemodialysis].
    del Pozo C, Ortiz de Salazar MI, Torregrosa I, Sánchez L, Albero MD, Bauza J.
    Nefrologia; 2000; 20(5):455-8. PubMed ID: 11100668
    [Abstract] [Full Text] [Related]

  • 2. Neutropenia of Felty's syndrome successfully treated with granulocyte colony stimulating factor.
    Fraser DD, Sartiano GP, Butler TW, Treadwell EL.
    J Rheumatol; 1993 Aug; 20(8):1447-8. PubMed ID: 7693942
    [No Abstract] [Full Text] [Related]

  • 3. A prolonged use of granulocyte colony stimulating factor in Felty's syndrome.
    Graham KE, Coodley GO.
    J Rheumatol; 1995 Jan; 22(1):174-6. PubMed ID: 7699667
    [Abstract] [Full Text] [Related]

  • 4. Resolution of the neutropenia of Felty's syndrome by longterm administration of recombinant granulocyte colony stimulating factor.
    Krishnaswamy G, Odem C, Chi DS, Kalbfleisch J, Baker N, Smith JK.
    J Rheumatol; 1996 Apr; 23(4):763-5. PubMed ID: 8730142
    [Abstract] [Full Text] [Related]

  • 5. Vasculitis complicating granulocyte colony stimulating factor treatment of leukopenia and infection in Felty's syndrome.
    Farhey YD, Herman JH.
    J Rheumatol; 1995 Jun; 22(6):1179-82. PubMed ID: 7545756
    [Abstract] [Full Text] [Related]

  • 6. Autoantibodies against granulocyte colony-stimulating factor in Felty's syndrome and neutropenic systemic lupus erythematosus.
    Hellmich B, Csernok E, Schatz H, Gross WL, Schnabel A.
    Arthritis Rheum; 2002 Sep; 46(9):2384-91. PubMed ID: 12355486
    [Abstract] [Full Text] [Related]

  • 7. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
    Wong SF, Chan HO.
    Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284
    [Abstract] [Full Text] [Related]

  • 8. Successful treatment of agranulocytosis and sepsis with granulocyte colony stimulating factor in a case of Felty's syndrome.
    Marfeuille M, Clerc D, Mariette X.
    J Rheumatol; 1995 Sep; 22(9):1803-4. PubMed ID: 8523369
    [No Abstract] [Full Text] [Related]

  • 9. Use of colony-stimulating factors in the treatment of neutropenia associated with collagen vascular disease.
    Starkebaum G.
    Curr Opin Hematol; 1997 May; 4(3):196-9. PubMed ID: 9209836
    [Abstract] [Full Text] [Related]

  • 10. Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L).
    Bruserud O, Foss B, Petersen H.
    Eur Cytokine Netw; 2001 May; 12(2):231-8. PubMed ID: 11399510
    [Abstract] [Full Text] [Related]

  • 11. Management of autoimmune neutropenia in Felty's syndrome and systemic lupus erythematosus.
    Newman KA, Akhtari M.
    Autoimmun Rev; 2011 May; 10(7):432-7. PubMed ID: 21255689
    [Abstract] [Full Text] [Related]

  • 12. Autoantibodies against granulocyte-macrophage colony stimulating factor and interleukin-3 are rare in patients with Felty's syndrome.
    Hellmich B, Ciaglo A, Schatz H, Coakley G.
    Ann Rheum Dis; 2004 Jul; 63(7):862-6. PubMed ID: 15194585
    [Abstract] [Full Text] [Related]

  • 13. [Clinical use of granulocyte colony stimulating-factors (GM-CSF and G-CSF].
    Borota R, Borota J, Belić A, Gebauer E, Stefanović N.
    Med Pregl; 1997 Jul; 50(3-4):87-93. PubMed ID: 9229690
    [Abstract] [Full Text] [Related]

  • 14. Treatment of severe neutropenia due to Felty's syndrome or systemic lupus erythematosus with granulocyte colony-stimulating factor.
    Hellmich B, Schnabel A, Gross WL.
    Semin Arthritis Rheum; 1999 Oct; 29(2):82-99. PubMed ID: 10553980
    [Abstract] [Full Text] [Related]

  • 15. [Report on the current indications for colony stimulating factors (G-CSF and GM-CSF)].
    Med Clin (Barc); 1994 May 21; 102(19):747-50. PubMed ID: 7518884
    [No Abstract] [Full Text] [Related]

  • 16. GM-CSF and G-CSF in Felty's syndrome.
    Wagner DR, Combe C, Gresser U.
    Clin Investig; 1993 Feb 21; 71(2):168-71. PubMed ID: 7681711
    [Abstract] [Full Text] [Related]

  • 17. Felty's syndrome.
    Balint GP, Balint PV.
    Best Pract Res Clin Rheumatol; 2004 Oct 21; 18(5):631-45. PubMed ID: 15454123
    [Abstract] [Full Text] [Related]

  • 18. Prolonged treatment with granulocyte colony-stimulating factor in a patient with Felty's syndrome and chronic renal failure from secondary amyloidosis.
    Del Pozo C, Sánchez L, Albero MD, Arenas MD.
    Nephrol Dial Transplant; 1997 Aug 21; 12(8):1727-9. PubMed ID: 9269662
    [No Abstract] [Full Text] [Related]

  • 19. Myeloid growth factors as anti-infective measures in children with leukemia and lymphoma.
    Lehrnbecher T, Creutzig U.
    Expert Rev Hematol; 2009 Apr 21; 2(2):159-72. PubMed ID: 21083449
    [Abstract] [Full Text] [Related]

  • 20. Long-term correction of neutropenia in Felty's syndrome with granulocyte colony-stimulating factor.
    Wandt H, Seifert M, Falge C, Gallmeier WM.
    Ann Hematol; 1993 May 21; 66(5):265-6. PubMed ID: 7685194
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.